These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38825802)

  • 1. Hydrophobic tagging of small molecules: an overview of the literature and future outlook.
    Zhou Y; Zhou F; Xu S; Shi D; Ding D; Wang S; Poongavanam V; Tang K; Liu X; Zhan P
    Expert Opin Drug Discov; 2024 Jul; 19(7):799-813. PubMed ID: 38825802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrophobic tag-based protein degradation: Development, opportunity and challenge.
    He Q; Zhao X; Wu D; Jia S; Liu C; Cheng Z; Huang F; Chen Y; Lu T; Lu S
    Eur J Med Chem; 2023 Nov; 260():115741. PubMed ID: 37607438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-Molecule Hydrophobic Tagging: A Promising Strategy of Druglike Technology for Targeted Protein Degradation.
    Xie S; Zhu J; Li J; Zhan F; Yao H; Xu J; Xu S
    J Med Chem; 2023 Aug; 66(16):10917-10933. PubMed ID: 37535706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced degradation of protein kinases by bifunctional small molecules: a next-generation strategy.
    Groppe JC
    Expert Opin Drug Discov; 2019 Dec; 14(12):1237-1253. PubMed ID: 31513432
    [No Abstract]   [Full Text] [Related]  

  • 5. Discovery of Norbornene as a Novel Hydrophobic Tag Applied in Protein Degradation.
    Xie S; Zhan F; Zhu J; Sun Y; Zhu H; Liu J; Chen J; Zhu Z; Yang DH; Chen ZS; Yao H; Xu J; Xu S
    Angew Chem Int Ed Engl; 2023 Mar; 62(13):e202217246. PubMed ID: 36670545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Induced degradation of proteins by PROTACs and other strategies: towards promising drugs].
    Reboud-Ravaux M
    Biol Aujourdhui; 2021; 215(1-2):25-43. PubMed ID: 34397373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small-Molecule Degraders beyond PROTACs-Challenges and Opportunities.
    Kastl JM; Davies G; Godsman E; Holdgate GA
    SLAS Discov; 2021 Apr; 26(4):524-533. PubMed ID: 33632029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of epigenetic degraders based on PROTAC, molecular glue, and hydrophobic tagging technologies.
    Peng X; Hu Z; Zeng L; Zhang M; Xu C; Lu B; Tao C; Chen W; Hou W; Cheng K; Bi H; Pan W; Chen J
    Acta Pharm Sin B; 2024 Feb; 14(2):533-578. PubMed ID: 38322348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular glue degraders: exciting opportunities for novel drug discovery.
    Lemaitre T; Cornu M; Schwalen F; Since M; Kieffer C; Voisin-Chiret AS
    Expert Opin Drug Discov; 2024 Apr; 19(4):433-449. PubMed ID: 38240114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The design, synthesis and bioactivity evaluation of novel androgen receptor degraders based on hydrophobic tagging.
    Sun Y; Wang H; Li Y; Li Z; Mao Z; Zhang M; Shao Y; Ye J; Li D; Shan L
    Bioorg Chem; 2024 May; 146():107309. PubMed ID: 38537338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Protein Degradation: An Emerging Therapeutic Strategy in Cancer.
    Barghout SH
    Anticancer Agents Med Chem; 2021; 21(2):214-230. PubMed ID: 32275492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of a PROTAC Mutant Huntingtin Degrader into Small-Molecule Hydrophobic Tags Focusing on Drug-like Properties.
    Hirai K; Yamashita H; Tomoshige S; Mishima Y; Niwa T; Ohgane K; Ishii M; Kanamitsu K; Ikemi Y; Nakagawa S; Taguchi H; Sato S; Hashimoto Y; Ishikawa M
    ACS Med Chem Lett; 2022 Mar; 13(3):396-402. PubMed ID: 35300080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degraders in epigenetic therapy: PROTACs and beyond.
    Dai XJ; Ji SK; Fu MJ; Liu GZ; Liu HM; Wang SP; Shen L; Wang N; Herdewijn P; Zheng YC; Wang SQ; Chen XB
    Theranostics; 2024; 14(4):1464-1499. PubMed ID: 38389844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of the antitumor effects of PARP inhibitors in triple-negative breast cancer via degradation by hydrophobic tagging modulation.
    Go A; Jang JW; Lee W; Ha JD; Kim HJ; Nam HJ
    Eur J Med Chem; 2020 Oct; 204():112635. PubMed ID: 32726747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New therapies on the horizon: Targeted protein degradation in neuroscience.
    Gregory JA; Hickey CM; Chavez J; Cacace AM
    Cell Chem Biol; 2024 Sep; 31(9):1688-1698. PubMed ID: 39303702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Acyl Thiourea-Based Hydrophobic Tagging Degraders Exert Potent Anti-Influenza Activity through Two Distinct Endonuclease Polymerase Acidic-Targeted Degradation Pathways.
    Ma X; Wang X; Chen F; Zou W; Ren J; Xin L; He P; Liang J; Xu Z; Dong C; Lan K; Wu S; Zhou HB
    J Med Chem; 2024 Jun; 67(11):8791-8816. PubMed ID: 38775356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel strategies and promising opportunities for targeted protein degradation: An innovative therapeutic approach to overcome cancer resistance.
    Zhu H; Wang J; Zhang Q; Pan X; Zhang J
    Pharmacol Ther; 2023 Apr; 244():108371. PubMed ID: 36871783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Strategies in Proteolysis-Targeting Chimeras (PROTACs): Highlights from 2022.
    Tamatam R; Shin D
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanding the ligand spaces for E3 ligases for the design of protein degraders.
    Shah Zaib Saleem R; Schwalm MP; Knapp S
    Bioorg Med Chem; 2024 May; 105():117718. PubMed ID: 38621319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted protein degradation in cancers: Orthodox PROTACs and beyond.
    Li J; Chen X; Lu A; Liang C
    Innovation (Camb); 2023 May; 4(3):100413. PubMed ID: 37033156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.